Abstract
Exendin-4, one of the most widely used antidiabetic drugs, has recently been reported to have potential antitumor effects in cancers. Prostate cancer (PC) is one of the most common cancers in male patients with type 2 diabetes mellitus, and radiotherapy plays a vital role in the therapy of PC. Whether exendin-4 has the potential to enhance PC response to ionizing radiation (IR) remains unknown. We aimed to explore whether exendin-4 radiosensitizes PC cells. GLP-1 receptor (GLP-1R) expression in PC tissue samples and cell lines were analyzed, Human prostate cancer cells (PC3 and LNCap) were treated with IR and exendin-4, and subjected to proliferation, clone formation, cell cycle, immunoblotting, and immunohistochemical analysis. An in situ prostate tumor of animal model was established. We found that GLP-1R was expressed in human PC tissues and cell lines. 1-100 nM exendin-4 promoted the anti-proliferation effects of IR in vitro and in vivo, and enhanced radiation-induced G2/M cycle arrest in PC cells in a dose-dependent manner. Furthermore, Ex-4 increased AMPK phosphorylation, decrease the levels of p-mTOR, cyclin B, and p34cdc2 . Our study suggested exendin-4 radiosensitizes PC cells via activation of AMPK A and subsequent in...Continue Reading
References
Mar 26, 2002·Biochemical Pharmacology·Iskandar IdrisRichard Donnelly
Feb 26, 2004·Circulation·Lazaros A NikolaidisRichard P Shannon
Aug 5, 2006·Annals of the New York Academy of Sciences·Patricia L Brubaker
Sep 13, 2008·Molecular and Cellular Endocrinology·Jens Juul HolstCarolyn F Deacon
Jun 27, 2009·The Review of Diabetic Studies : RDS·Arie GruzmanShlomo Sasson
Jul 10, 2010·International Journal of Radiation Oncology, Biology, Physics·Toran SanliTheodoros Tsakiridis
May 17, 2011·Cell Cycle·Alexa S GreenJerome Tamburini
Jun 4, 2011·Breast Cancer Research and Treatment·Hagai LigumskyTami Rubinek
Jul 1, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Vanessa E ZannellaMarianne Koritzinsky
Jul 21, 2011·Endocrinology·Jacqueline A KoehlerDaniel J Drucker
Oct 28, 2011·Radiation Oncology·Ayesha RashidTheodoros Tsakiridis
Apr 14, 2012·Scientific Reports·Chang W SongHeon Joo Park
Oct 17, 2012·Diabetes Care·Manfredi TesauroCarmine Cardillo
Nov 20, 2012·Journal of Hepatology·Susan Leanne Samson, Mandeep Bajaj
May 2, 2013·British Journal of Cancer·Y StorozhukT Tsakiridis
Sep 3, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Dong HanMan-Xiang Li
Dec 20, 2013·International Journal of Molecular Sciences·Ben-Dong ChenQi Wang
Apr 15, 2014·Disease-a-month : DM·Daniel M SamanMartin S Lipsky
Jun 1, 2014·Diabetes·Takashi NomiyamaToshihiko Yanase
Feb 25, 2015·The Journal of Clinical Endocrinology and Metabolism·Robert L PlewsJohn E Phay
Apr 14, 2015·PloS One·Julie SesenNicolas Skuli
May 27, 2015·PloS One·Vanessa HoangArpita K Vyas
Jun 27, 2015·PloS One·Zhao LiuShui Wang
Aug 10, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Robert F WolffJos Kleijnen
Sep 24, 2015·Oncology Reports·Nianshuang LiLingyu Luo
Dec 10, 2015·Oncology Reports·Yu ZhangJianping Weng
Jul 28, 2016·Biochemical and Biophysical Research Communications·Nana LiWenyan Niu
Jul 31, 2016·Journal of Translational Medicine·Francesco AndreozziFranco Folli
Aug 9, 2016·Molecular and Cellular Endocrinology·Wenjing HeHaipeng Xiao
Oct 7, 2016·International Journal of Immunopathology and Pharmacology·Chethan Gejjalagere Honnappa, Unnikrishnan Mazhuvancherry Kesavan